Occam Crest Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,000
Closed -$658K 32
2025
Q3
$658K Buy
+2,000
New +$5.65K 0.4% 29

Other funds holding PGEN

Occam Crest Management's PGEN Position: Q2 2026 in Review

Occam Crest Management reduced its Precigen (PGEN) stake by 16% in Q2 2026, selling an estimated $2.87M and leaving 3,605,941 shares worth $19.7M. The position accounts for 10.2% of the portfolio, ranked #2.

Occam Crest Management first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Occam Crest Management held 3,605,941 shares of Precigen worth $19.7M as of Q2 2026.
  • Occam Crest Management sold 663,110 Precigen shares in Q2 2026, an estimated $2.87M.
  • Precigen made up 10.2% of Occam Crest Management's portfolio in Q2 2026, its #2 holding.
  • Occam Crest Management first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Occam Crest Management's 13F filing for Q2 2026, filed 14 Aug 2026.